Stockhead on MSN4d
Dimerix banks initial $3.2m payment in Japanese pharma licensing deal for kidney drugSpecial Report: Dimerix has received the initial payment of ¥300 million (A$3.2 million) in line with its recently announced ...
Australian healthcare sector leaders believe while progress has been made further work is needed to see more women in senior ...
HotCopper on MSN5d
Dimerix posts modest gain as first Japanese payment for DMX-200 landsDimerix Ltd (ASX:DXB) has confirmed its receipt of its first $3.2 million payment from Japan’s FUSO Pharmaceutical Industries ...
Stockhead on MSN4d
Health Check: Half-price sale as brokers ring the bell on Neuren sharesHealthcare analysts believe that shares in rare neurological share play Neuren Pharmaceuticals are well undervalued after a ...
Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 27 years, gives his ...
Dimerix pursues new product concepts and applies scientific knowledge to the discovery of products from early stage development through to commercialisation.
AVH.AX AVITA Medical, Inc.
As of 5 March at 10:36:56 am AEDT. Market open.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback